Amgen's research and development facility in San Francisco. (courtesy photo) Thousand Oaks-based biotech giant Amgen saw total revenues of $36.8 billion in 2025, a 10% hike over 2024, according to the global firm’s 2025 and fourth quarter earnings report released Feb. 3. "Amgen delivered strong performance in 2025, with double-digit growth in revenues and earnings…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
